Panhematin for Prevention of Acute Attacks of Porphyria

NCT02922413 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Acute Intermittent Porphyria
Hereditary Coproporphyria
Variegate Porphyria

Interventions

BIOLOGICAL: Hemin for injection
OTHER: Placebo

Sponsor

The University of Texas Medical Branch, Galveston